This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohen, F. J. Articles by Demers, L. Search for Related Content PubMed PubMed Citation Articles by Cohen, F. J. Articles by Demers, L.

Involvement of the Polyamine Pathway in Antiestrogen-induced Growth Inhibition of Human Breast Cancer¹

Departments of Medicine, Pathology and Behavioral Science, The Milton S. Hershey Medical Center, The Pennsylvania State University, Hershey, Pennsylvania 17033

Recent evidence indicates that the antiestrogen tamoxifen (TAM) may inhibit breast cancer cell proliferation, at least in part, through suppression of the polyamine (PA) pathway. To directly test this hypothesis, we evaluated the effect of TAM administration on ornithine decarboxylase (ODC) activity, the rate-limiting enzyme in PA synthesis, as well as cellular PA levels in the hormone-responsive MCF-7 breast cancer cell line in culture. In detailed time course studies, we observed that TAM significantly inhibited the rise in ODC activity observed in control cells following a medium change. Chronic treatment with escalating amounts of TAM caused a dose-related decrease in tumor pools of putrescine and spermidine, while spermine levels were unaffected. The TAM effects on ODC activity and PA pools were reversible with exogenous estradiol administration. However, addition of putrescine to TAM-treated cells did not result in a reversal of the antiproliferative effect of TAM, despite repletion of cellular PA pools. Administration of TAM to the hormone-independent MDA-MB-231 breast cancer cell line did not suppress ODC activity or cellular PA levels despite induction, at high concentrations, of an estradiol-irreversible inhibition of proliferation. We conclude that, in the hormone-responsive MCF-7 breast cancer cell line, TAM causes a significant suppression of the PA pathway, the relation of which, if any, to its antiproliferative action remains obscure. This effect seems to be mediated through the estrogen receptor and does not appear to be a nonspecific consequence of inhibition of cell proliferation.

¹ This work is supported by a grant from the National Cancer Institute, PO1 CA40011.

² To whom requests for reprints should be addressed, at Division of Endocrinology, The Milton S. Hershey Medical Center, P. O. Box 850, Hershey, PA 17033.

Received 4/22/88. Revised 7/25/88. Accepted 8/26/88.

This article has been cited by other articles:

				Y. Huang, J. C. Keen, A. Pledgie, L. J. Marton, T. Zhu, S. Sukumar, B. H. Park, B. Blair, K. Brenner, R. A. Casero Jr, et al. Polyamine Analogues Down-regulate Estrogen Receptor {alpha} Expression in Human Breast Cancer Cells J. Biol. Chem., July 14, 2006; 281(28): 19055 - 19063. [Abstract] [Full Text] [PDF]

				V. Vijayanathan, S. Venkiteswaran, S. K. Nair, A. Verma, T.J. Thomas, B. T. Zhu, and T. Thomas Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells. Clin. Cancer Res., April 1, 2006; 12(7 Pt 1): 2038 - 2048. [Abstract] [Full Text] [PDF]